Daniel Rivera
Impact in
- Hepatology top 5%
- Liver physiology and pathology
-
- Nanoparticle-Based Drug Delivery
Papers in
- Genetics 7
- Glioma Diagnosis and Treatment 7
-
- Nanoparticle-Based Drug Delivery 2
- Co-authors
- Alexandros Bouras (8 shared papers)Costas G. Hadjipanayis (7 shared papers)Joe Gerald Jesu Raj (3 shared papers)Dominique Bozec (3 shared papers)Georgios P. Skandalakis (1 shared paper)Danielle Laure Taneyo Saa (1 shared paper)Lidia Tomás‐Cobos (1 shared paper)Andrea Gianotti (1 shared paper)
- Journals
- The FASEB Journal (4 papers)Applied Sciences (1 paper)Nanoscale Research Letters (1 paper)International Journal of Hyperthermia (1 paper)LWT (1 paper)
- Partner nations
- United StatesPuerto RicoSwitzerland
In The Last Decade
Daniel Rivera
23 papers receiving 679 citations
Peers
Comparison fields: 5 of 62
- Hepatology 146
- Biomaterials 56
- Genetics 33
- Drug Discovery 1
- Molecular Biology 218
Countries citing papers authored by Daniel Rivera
This map shows the geographic impact of Daniel Rivera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Rivera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Rivera more than expected).
Fields of papers citing papers by Daniel Rivera
This network shows the impact of papers produced by Daniel Rivera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Rivera. The network helps show where Daniel Rivera may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Rivera, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 275 | |
| 2 | 2020 | 94 | |
| 3 | 2013 | 89 | |
| 4 | 2018 | 47 | |
| 5 | 2021 | 47 | |
| 6 | 2024 | 30 | |
| 7 | 2020 | 17 | |
| 8 | 2011 | 15 | |
| 9 | 2025 | 15 | |
| 10 | 2023 | 14 | |
| 11 | 2014 | 12 | |
| 12 | 2014 | 8 | |
| 13 | 2025 | 7 | |
| 14 | 2014 | 6 | |
| 15 | 2022 | 6 | |
| 16 | 2024 | 4 | |
| 17 | 2011 | 3 | |
| 18 | 2021 | 2 | |
| 19 | 2024 | 2 | |
| 20 | 2024 | 2 |
About Daniel Rivera
Daniel Rivera is a scholar working on Genetics, Biomaterials, Biomedical Engineering, Materials Chemistry and Neurology, having authored 24 papers that have together received 698 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (7 papers), Nanoparticles: synthesis and applications (4 papers), Nanoplatforms for cancer theranostics (3 papers), Characterization and Applications of Magnetic Nanoparticles (3 papers), Ultrasound and Hyperthermia Applications (2 papers), Nanoparticle-Based Drug Delivery (2 papers), Intracranial Aneurysms: Treatment and Complications (2 papers) and Wnt/β-catenin signaling in development and cancer (2 papers). The work is most often cited by research in Hepatology (146 citations), Biomaterials (56 citations), Genetics (33 citations), Drug Discovery (1 citation) and Molecular Biology (218 citations). Daniel Rivera has collaborated with scholars based in United States, Puerto Rico and Switzerland. Frequent co-authors include Alexandros Bouras, Costas G. Hadjipanayis, Joe Gerald Jesu Raj, Dominique Bozec, Georgios P. Skandalakis, Danielle Laure Taneyo Saa, Lidia Tomás‐Cobos, Andrea Gianotti, Małgorzata Anita Bryszewska and Kenneth R. Hallows. Their work appears in journals such as The FASEB Journal, Applied Sciences, Nanoscale Research Letters, International Journal of Hyperthermia and LWT.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.